Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.
I think SP actually held very well today and recovery we witnessed only shows that more and more shares are in sticky hands. News like that last year caused massive sell off, today only 5%.
I used this opportunity to top up.
Moderna is 25% down
They increased appetite for SNG shares considerably since activ-2 progression.
Looks like they think it massively de-risked company future in their opinion. It took them 8 months to built 10% and only a month to built another 4.2%
Phase 3 trials for respiratory drugs are 80% successful, but that 80% is on average .
We are during pandemic, we had amazing p2 results and we were good enough to progress to p3 in activ-2.
I can’t see this not being north of 80%
Standard for p3 respiratory drugs is 80%.
We have brilliant p2 results, home trial p2 results, activ-2 progression and biggest pandemic of this century.
Probability of success is north of 90%, probably closer to 95%